Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: The Scientific Basis of Rheumatology

Perspectives for TNF-α-targeting therapies

Hanns-Martin Lorenz* and Joachim R Kalden

Arthritis Res 2002, 4(Suppl 3):S17-S24 doi:10.1186/ar564


London, UK. 24-26 June 2002

Accesses  

  • Last 30 days: 64 accesses
  • Last 365 days: 740 accesses
  • All time: 12891 accesses

Cited by

BioMed Central: 2 citations